ClinicalTrials.gg
Not yet recruitingNCT06292234Updated Apr 19, 2024

Patient Specific Implant Versus Miniplates for Advancement of Hypoplastic Maxilla

An interventional study of PSI and Conventional miniplates in Cleft Lip and Palate, sponsored by Cairo University. Not yet recruiting. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2024-04-19.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Distraction osteogenesis is the treatment of choice in management of severe maxillary anteroposterior deficiency allowing for a progressive bone generation and simultaneous expansion of the surrounding scarred soft tissue \& better long-term stability \& less relapse rate.

Read the detailed description

Maxillary distraction using rigid external distraction device (RED) with skeletal anchorage in cleft lip and palate overcomes the disadvantages of tooth brone RED \& showed reliable advancement \& reasonable relapse rate in the short \& long-term follow up \& most importantly it solved somehow counterclockwise rotation of maxilla but still it can occur. Positioning of plates in relation to center of resistance of maxilla to adjust vector of distraction can be done now by using Virtual surgical planning (VSP) \& fabrication of patient specific implants (PSI) to overcome problems encountered with use of conventional miniplates during distraction process. Limited data in literature with no randomized clinical trials were done to assess distraction effectiveness using PSI in RED with skeletal anchorage and its effect on velopharyngeal insufficiency (VPI) \& speech. Based on that data, the research will compare distraction effectiveness, VPI \& speech between using either PSI implants or miniplates for distraction.

02

Conditions studied

  • Cleft Lip and Palate

Browse trials for

03

In context

Cleft Lip

168 studies on the registry are indexed under Cleft Lip; 51 are open to participants now.

This study's planned enrollment of 20 is below the median of 30 across 116 interventional studies indexed under Cleft Lip.

Browse Cleft Lip studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Non growing cleft patients, age range (18-30 years)
  2. Unilateral or bilateral cleft patients
  3. Anteroposterior deficiency (1.5-2.5 cm)
  4. No sex predilection

Exclusion criteria

Exclusion Criteria:

  1. Syndromic patients.
  2. bone metabolism \& systemic diseases.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    patient specific implants

    Custom made designed implants

    Device: PSI

  • Active comparator
    miniplates

    Over the counter miniplates

    Device: Conventional miniplates

Interventions

  • DevicePSI

    Fabrication of PSI implants using virtual surgical planning

  • DeviceConventional miniplates

    Ready made miniplates

06

What researchers measure

Primary outcomes

  1. Distraction effectiveness

    Amount of distraction using Lateral Cephalometry \& FBCT measured in millimeters (mm)

    Time frame: immediate postoperative, 4 months postoperatively, 10 months postoperatively

Secondary outcomes

  1. Velopharyngeal insufficiency

    Scoring from 0 to 4; 0: Normal, 1: minimal, 2: mild, 3: moderate, 4: sever using endoscopy

    Time frame: Preoperative , 4 months postoperatively, 10 months postoperatively

  2. Speech

    Nasometry Speech assessment; 1=absent, 2=mild, 3=mild to moderate, 4=moderate, 5=moderate to severe and 6=severe.

    Time frame: preoperative, 4 months postoperatively, and 10 months postoperatively

  3. Operative time

    Measuring the time of the procedures in minutes

    Time frame: Immediate postoperative

  4. Wound dehiscence

    Clinical assessment of presence or absence of wound dehiscence (Binary: Yes or No)

    Time frame: immediate postoperative till 4 months postoperatively

  5. Infection

    Clinical assessment of presence or absence of infection (Binary: Yes or No)

    Time frame: immediate postoperative till 4 months postoperatively

  6. Nerve affection

    Clinical assessment of presence or absence of nerve affection (Binary: Yes or No)

    Time frame: immediate postoperative till 4 months postoperatively

  7. Screw loosening

    Clinical assessment of presence or absence of screw loosening (Binary: Yes or No)

    Time frame: immediate postoperative till 4 months postoperatively

  8. Overall complications

    Clinical assessment of presence or absence of complications (Binary: Yes or No)

    Time frame: immediate postoperative, 4 months postoperatively and 10 months postoperatively

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2024; primary completion for Feb 2025, 9 months later.

Of 64 non-industry interventional studies with no phase under Cleft Lip, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 33. This study's planned 9 months is below that.

Counting every sponsor, half of 65 studies reached it within 22 months; a quarter within 15 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2024
First posted
Mar 5, 2024
StartEst.
May 1, 2024
Primary completionEst.
Feb 1, 2025
CompletionEst.
Mar 1, 2025
Last update
Apr 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06292234
Lead sponsor
Cairo University
Responsible party
Hagar Mahmoud Ahmed Mohamed (Principal investigator, Phd candidate, Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Cairo University) — Principal investigator
First posted
Mar 5, 2024
Start date
May 1, 2024 (estimated)
Primary completion
Feb 1, 2025 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Apr 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion